STOCK TITAN

AVITA Medical (RCEL) director adds 5,200 shares in open-market buy

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

AVITA Medical, Inc. director Woody Joseph Fralin made an open-market purchase of the company’s common stock. On June 9, 2026, he bought 5,200 shares at $4.00 per share, bringing his direct holdings to 107,961 shares, which the disclosure notes include unvested RSUs.

Positive

  • None.

Negative

  • None.
Insider Woody Joseph Fralin
Role null
Bought 5,200 shs ($21K)
Type Security Shares Price Value
Purchase Common Stock 5,200 $4.00 $21K
Holdings After Transaction: Common Stock — 107,961 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares purchased 5,200 shares Open-market purchase on June 9, 2026
Purchase price $4.00 per share Common stock transaction price
Total holdings after transaction 107,961 shares Direct ownership following June 9, 2026 purchase
Net buy shares 5,200 shares Net change in share ownership reported in Form 4
open-market purchase financial
"described as an open-market purchase of the company’s common stock"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Form 4 regulatory
"The Form 4 identifies Woody Joseph Fralin’s ownership as direct"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
restricted stock units (RSUs) financial
"the reported total of 107,961 shares includes unvested restricted stock units (RSUs)"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
transaction code “P” regulatory
"The transaction is coded as “P,” which the Form 4 describes"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did AVITA Medical (RCEL) disclose for Woody Joseph Fralin?

AVITA Medical reported that director Woody Joseph Fralin executed an open-market purchase of the company’s common stock. He bought 5,200 shares on June 9, 2026 at a price of $4.00 per share, increasing his overall direct share ownership position.

How many AVITA Medical (RCEL) shares did Woody Joseph Fralin buy and at what price?

Woody Joseph Fralin purchased 5,200 shares of AVITA Medical common stock in an open-market transaction. The reported purchase price was $4.00 per share, as disclosed in the Form 4 insider trading report filed for the June 9, 2026 transaction date.

What is Woody Joseph Fralin’s total AVITA Medical (RCEL) ownership after this Form 4 transaction?

Following the reported purchase, Woody Joseph Fralin directly owns 107,961 shares of AVITA Medical common stock. The filing states that this total includes unvested restricted stock units (RSUs), which are part of his equity-based compensation and have not yet fully vested.

Does the AVITA Medical (RCEL) Form 4 indicate whether the shares are held directly or indirectly?

The Form 4 identifies Woody Joseph Fralin’s ownership as direct, indicated by the ownership code “D.” This means the purchased and reported 107,961 shares, including unvested RSUs, are held in his own name rather than through a separate entity or trust.

What type of transaction code appears in Woody Joseph Fralin’s AVITA Medical (RCEL) Form 4?

The transaction is coded as “P,” which the Form 4 describes as a purchase in an open market or private transaction. This confirms the event as a straightforward buy of common stock rather than an option exercise, gift, or tax-related share withholding.

Are unvested RSUs included in Woody Joseph Fralin’s AVITA Medical (RCEL) holdings total?

Yes. A footnote to the Form 4 explicitly states that the reported total of 107,961 shares includes unvested restricted stock units (RSUs). These RSUs represent share-based awards that are scheduled to vest over time according to the company’s equity compensation terms.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Woody Joseph Fralin

(Last)(First)(Middle)
C/O AVITA MEDICAL 28159 AVENUE STANFORD
SUITE 220

(Street)
VALENCIA CALIFORNIA 91355

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AVITA Medical, Inc. [ RCEL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/09/2026P5,200A$4107,961(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Includes unvested RSUs
/s/ Nicole Kelsey, by power of attorney06/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)